Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 27 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

11%

3 trials in Phase 3/4

Results Transparency

15%

4 of 27 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (3)
P 1 (19)
P 4 (3)

Trial Status

Completed27

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT05237297Phase 1CompletedPrimary

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole

NCT05558150Phase 1CompletedPrimary

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac

NCT03123640Not ApplicableCompleted

Improving Drug Safety in Emergency Patients -a Randomized Controlled Trial

NCT03493698Phase 1CompletedPrimary

A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects

NCT03886701Phase 1Completed

Doravirine, Rifapentine and Isoniazid Interaction

NCT02378220Not ApplicableCompleted

Pharmacogenetic Testing Among Home Health Patients

NCT02077556Phase 4CompletedPrimary

Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients

NCT03801733Phase 1CompletedPrimary

Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin

NCT03789032Phase 1CompletedPrimary

Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat

NCT03801759Phase 1CompletedPrimary

Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and Furosemide

NCT03801746Phase 1CompletedPrimary

Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin

NCT03706222CompletedPrimary

Drug-Drug Interactions of Grazoprevir/Elbasvir in Taiwan

NCT01896557Phase 4Completed

Ranitidin Versus Omeprazole in Patients Taking Clopidogrel

NCT03259542Phase 1CompletedPrimary

Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor

NCT03126578Phase 1CompletedPrimary

Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam

NCT03011463Phase 1Completed

Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for OCT1

NCT01369186Phase 4CompletedPrimary

Drug Drug Interactions of Aspirin and P2Y12-inhibitors

NCT02191358Completed

YouScript IMPACT Registry

NCT02998437Phase 1CompletedPrimary

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole

NCT02500667Phase 1CompletedPrimary

A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects

Scroll to load more

Research Network

Activity Timeline